| Dr Norman Clifford Denton, MD | |
|
900 N 7th St, West Memphis, AR 72301-2001 | |
| (870) 735-3842 | |
| Not Available |
| Full Name | Dr Norman Clifford Denton |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 26 Years |
| Location | 900 N 7th St, West Memphis, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881612059 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 39715 (Tennessee) | Secondary |
| 207W00000X | Ophthalmology | E-6764 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Arkansas Family Health Center, Inc | 1052390390 | 25 |
News Archive
As they grow older, teenagers are spending more time in front of the computer and television and less time participating in physical activities, according to researchers at the University of Minnesota School of Public Health.
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
› Verified 2 days ago
| Entity Name | East Arkansas Family Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871599613 PECOS PAC ID: 1052390390 Enrollment ID: O20040719001289 |
News Archive
As they grow older, teenagers are spending more time in front of the computer and television and less time participating in physical activities, according to researchers at the University of Minnesota School of Public Health.
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
› Verified 2 days ago
| Entity Name | East Arkansas Family Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659506095 PECOS PAC ID: 1052390390 Enrollment ID: O20101006000058 |
News Archive
As they grow older, teenagers are spending more time in front of the computer and television and less time participating in physical activities, according to researchers at the University of Minnesota School of Public Health.
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
› Verified 2 days ago
| Entity Name | East Arkansas Family Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578889622 PECOS PAC ID: 1052390390 Enrollment ID: O20110503000659 |
News Archive
As they grow older, teenagers are spending more time in front of the computer and television and less time participating in physical activities, according to researchers at the University of Minnesota School of Public Health.
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
› Verified 2 days ago
| Entity Name | East Arkansas Family Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912370198 PECOS PAC ID: 1052390390 Enrollment ID: O20160114002062 |
News Archive
As they grow older, teenagers are spending more time in front of the computer and television and less time participating in physical activities, according to researchers at the University of Minnesota School of Public Health.
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Norman Clifford Denton, MD 900 N 7th St, West Memphis, AR 72301-2001 Ph: (870) 735-3842 | Dr Norman Clifford Denton, MD 900 N 7th St, West Memphis, AR 72301-2001 Ph: (870) 735-3842 |
News Archive
As they grow older, teenagers are spending more time in front of the computer and television and less time participating in physical activities, according to researchers at the University of Minnesota School of Public Health.
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
› Verified 2 days ago
Glen Edward Bryant Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 303 W Polk, Suite A, West Memphis, AR 72301 Phone: 870-732-2100 Fax: 870-732-3027 |